72 filings
8-K
BioAmber Inc.
26 Oct 18
BioAmber Provides Update on Liquidation Process
4:55pm
8-K
BioAmber Inc.
4 Sep 18
BioAmber Provides Update on Liquidation ProcessĀ & Announces Resignations
12:00am
8-K
BioAmber Inc.
14 Aug 18
BioAmber Provides Update on Liquidation Process
4:05pm
8-K
BioAmber Inc.
1 Aug 18
BioAmber Provides Update on Sales Process
5:12pm
8-K
BioAmber Inc.
20 Jun 18
BioAmber Receives Favourable Court Ruling and Approval for DIP Financing
8:38am
8-K
mx9s0 98rudpi
8 May 18
BioAmber Announces Filing for Stay of Proceedings on Creditors
4:16pm
8-K
mlux37jp
16 Feb 18
BioAmber Inc. Receives Notice of Delisting by TSX
12:00am
8-K
g0tzo
15 Feb 18
BioAmber Inc. Receives Notice of Delisting Review by TSX
12:00am
8-K
3acfbwk7l bnkwxylx0
13 Feb 18
BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering
12:00am
8-K
09rpwlj
8 Feb 18
Bioamber Inc. Announces Pricing of US$10 Million Underwritten Public Offering
12:00am
8-K/A
e7pqab0u0vf9
6 Feb 18
Regulation FD Disclosure
12:00am
8-K
kgkg6mgmony33f kedb9
5 Feb 18
Bioamber Inc. Announces Underwritten Offering
12:00am
8-K
6oisf8vmpbn5j
26 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
0vguw 4iays
8 Nov 17
BioAmber Announces Third Quarter 2017 Financial Results
12:00am
8-K
7ugaay blh
24 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
25ow6wtn0 rr1l6xt
14 Sep 17
BioAmber Announces New Chief Executive Officer
12:00am
8-K
10gk6c
13 Sep 17
BioAmber Inc. Receives Notice of Non-Compliance from the NYSE
12:00am
8-K
0axbfq egcmac
11 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
5pj26xk9cp54oc30b6w
3 Aug 17
Bioamber Announces Record Revenues for the Second Quarter 2017 and Purchase of Mitsui Equity Stake In Sarnia Joint Venture
12:00am
8-K
uvlb357h7oex9flk l5
15 May 17
BioAmber Announces Changes to its Board of Directors, the Appointment of a
12:00am